PENGARUH CURRENT RATIO (CR) DAN DEBT TO EQUITY RATIO (DER) TERHADAP RETURN ON ASSET (ROA) PADA SUB SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA

This study aims to examine the effect of the Current Ratio (CR) and Debt to Equity Ratio (DER) on Return on Assets (ROA) in pharmaceutical manufacturing companies listed on the Indonesia Stock Exchange. The research method used is quantitative with a multiple linear regression approach. The data used is secondary data obtained from the company's financial statements for the period 2021-2023. The results show that both the Current Ratio (CR) and the Debt to Equity Ratio (DER) have a significant effect on Return on Assets (ROA). However, DER has a greater effect than CR on ROA, although it remains significant. This indicates that other factors beyond CR and DER play a greater role in determining company profitability. The conclusion of this study is that liquidity ratios and capital structure, as measured by CR and DER, significantly influence the profitability of pharmaceutical companies.